Skip to main content

Kloxxado News (Page 2)

FDA Approves Kloxxado (naloxone hydrochloride) Nasal Spray for Emergency Treatment of Opioid Overdose

LONDON, April 30, 2021 /PRNewswire/ – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the approval of Kloxxado (naloxone hydrochloride) nasal spray 8mg, by the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Opioid Overdose

Kloxxado patient information at Drugs.com